ClinicalTrials.Veeva

Menu

Noninvasive Spinal Stimulation to Restore Hand Function in Children with Spinal Cord Injury

University of Louisville (UOFL) logo

University of Louisville (UOFL)

Status

Not yet enrolling

Conditions

Spinal Cord Injury Cervical

Treatments

Device: Activity based upper extremity training with and without stimulation

Study type

Interventional

Funder types

Other

Identifiers

NCT06489106
24.0267

Details and patient eligibility

About

The main goal of this pilot study is to find the best ways to use transcutaneous spinal cord stimulation (scTS) to improve hand function in children with spinal cord injuries (SCI). The investigators will start by exploring the best places and strengths for applying scTS on the neck, the added benefits of applying scTS on the lower back (T11-T12), and comparing the effects of using activity based upper extremity training (a control treatment) alone versus combining it with scTS to help children with chronic SCI regain hand function.

Full description

After learning about the study and potential risks, parents/legal guardians and their eligible children with SCI will sign consent and assent forms, respectively. For the first two aims of the study, the investigators will recruit and enroll 10 participants. In the first week, participants will undergo clinical assessments from day 1 to day 4 to categorize the severity and level of their injuries and assess their current arm and hand function. On day 5, eligible participants will have experimental assessments to measure hand grip and control, both with and without spinal cord stimulation (scTS) at one or two neck sites optimized to improve hand grip. On day 6, participants will have similar assessments, this time adding stimulation to the trunk area to help with upright sitting and study its impact on hand grip and control.

For the third aim, 4 participants who showed improved hand grip and control with stimulation in aims 1 and 2 will be selected on a first-come, first-served basis. They will undergo 20 sessions of activity-based upper extremity training, followed by 20 more sessions with the optimal stimulation sites identified from aims 1 and 2. After completing the training, participants will be asked to follow up and repeat experimental and clinical assessments to determine how long the improvements last.

Enrollment

10 estimated patients

Sex

All

Ages

7 to 12 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

For aim 1 and 2, 10 participants with SCI:

  1. age 7-12 years;
  2. chronic (>6 months), acquired upper motor neuron SCI;
  3. cervical SCI at or above C8 neurological level with motor score of 1-3 for finger flexors
  4. Pediatric Neurorecovery scale score of ≥2B and ≤ 4C for impaired grip

For Aim 3, 4 participants with SCI who:

  1. complete aim 1 and 2;
  2. consent/assent for aim 3
  3. demonstrate a minimum of 10% increase in HG force with scTS (aim1-2)
  4. confirmed volitional activation in hand muscles during hang grip assessment without scTS

Exclusion criteria

For all 3 aims will include:

  1. Botox use within past 3 months (for upper or lower extremity);
  2. current oral baclofen (or pump);
  3. musculoskeletal impairment limiting range of motion;
  4. unhealed fracture or other medical condition limiting participation in AB-UET;
  5. etiology of spina bifida;
  6. total ventilator dependence.

Trial design

Primary purpose

Treatment

Allocation

Non-Randomized

Interventional model

Crossover Assignment

Masking

None (Open label)

10 participants in 2 patient groups

Activity based upper extremity training
Active Comparator group
Description:
Activity-based upper extremity training (AB-UET) will be administered 5d/week and 1 hour 30 minutes/session.
Treatment:
Device: Activity based upper extremity training with and without stimulation
Activity based upper extremity training with stimulation
Experimental group
Description:
Activity-based upper extremity training (AB-UET + scTS) will be administered 5d/week and 1 hour 30 minutes/session. UE tasks will be repeated with and without scTS so that scTS is administered intermittently for the duration of \~ 10 minute/bouts.
Treatment:
Device: Activity based upper extremity training with and without stimulation

Trial contacts and locations

0

Loading...

Central trial contact

Lisa Clayton, MS

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems